If you’ve been keeping an eye on recent headlines for ophthalmology clinical studies and research focusing on age-related macular degeneration (AMD), the news has not been optimistic.
A Window of Opportunity for Ophthalmology Clinical Trials in AMD
;
;
About the Author: Nick Spittal is VP of Clinical Development for Syneos Health™ overseeing the global Ophthalmology Team. Nick has consulted on Clinical programs for many ophthalmic diseases from proof-of-concept through registration and overseen teams responsible for the largest programs executed in wet and dry AMD, DME and RVO.
To download the free whitepaper, fill out the form below:
